MX2017013122A - Metodos de reparacion y regeneracion tisular. - Google Patents

Metodos de reparacion y regeneracion tisular.

Info

Publication number
MX2017013122A
MX2017013122A MX2017013122A MX2017013122A MX2017013122A MX 2017013122 A MX2017013122 A MX 2017013122A MX 2017013122 A MX2017013122 A MX 2017013122A MX 2017013122 A MX2017013122 A MX 2017013122A MX 2017013122 A MX2017013122 A MX 2017013122A
Authority
MX
Mexico
Prior art keywords
site
injury
induces
regeneration
tissue
Prior art date
Application number
MX2017013122A
Other languages
English (en)
Inventor
James Kang Yujian
Original Assignee
Innolife Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innolife Co Ltd filed Critical Innolife Co Ltd
Publication of MX2017013122A publication Critical patent/MX2017013122A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Prostheses (AREA)

Abstract

La divulgación proporciona el suministro local de un elemento traza en un sitio de daño tisular, que desencadena el mecanismo de reparación tisular inherente del cuerpo. El suministro local de cobre en el sitio de la lesión induce la migración (es decir, la migración dirigida) de células madre hacia el sitio de la lesión, desencadena la diferenciación de células madre en el sitio de la lesión, induce la regeneración tisular en el sitio de la lesión, induce moléculas de señalización que desencadenan la regeneración tisular, revierte el daño en el sitio de la lesión y/o reconstruye el microambiente de células neurofibrilares y células neurosecretoras en el sitio de la lesión. En otro aspecto, se desvela el suministro de un elemento traza (por ejemplo, cobre) directamente en el sitio de la lesión y los métodos asociados.
MX2017013122A 2015-04-22 2016-04-08 Metodos de reparacion y regeneracion tisular. MX2017013122A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2015/077136 WO2016168993A1 (en) 2015-04-22 2015-04-22 Methods of tissue repair and regeneration
PCT/CN2016/078873 WO2016169416A1 (en) 2015-04-22 2016-04-08 Methods of tissue repair and regeneration

Publications (1)

Publication Number Publication Date
MX2017013122A true MX2017013122A (es) 2018-06-18

Family

ID=57142823

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017013122A MX2017013122A (es) 2015-04-22 2016-04-08 Metodos de reparacion y regeneracion tisular.

Country Status (25)

Country Link
US (1) US11077138B2 (es)
EP (1) EP3285782B1 (es)
JP (2) JP6895388B2 (es)
KR (2) KR102347010B1 (es)
CN (1) CN107921062B (es)
AU (1) AU2016250971B2 (es)
BR (1) BR112017022355A2 (es)
CA (1) CA2982840C (es)
CL (1) CL2017002600A1 (es)
CO (1) CO2017010382A2 (es)
DK (1) DK3285782T3 (es)
EA (1) EA038598B1 (es)
EC (1) ECSP17068922A (es)
ES (1) ES2898655T3 (es)
HK (2) HK1247825A1 (es)
HU (1) HUE056650T2 (es)
IL (1) IL255116B (es)
MX (1) MX2017013122A (es)
MY (1) MY189322A (es)
NZ (1) NZ736516A (es)
PE (1) PE20180240A1 (es)
SG (1) SG11201708431QA (es)
TW (1) TWI702956B (es)
UA (1) UA124332C2 (es)
WO (2) WO2016168993A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016168993A1 (en) 2015-04-22 2016-10-27 Innolife Co., Ltd. Methods of tissue repair and regeneration
WO2017049529A1 (en) 2015-09-24 2017-03-30 Innolife Co., Ltd. A pharmaceutical composition comprising a copper chelating tetramine and the use thereof
CN106754662B (zh) * 2016-11-21 2019-11-12 中国人民解放军军事医学科学院基础医学研究所 心肌细胞的制备方法
TWI615127B (zh) * 2017-01-17 2018-02-21 正崴精密工業股份有限公司 計算血壓的方法及其裝置
WO2018217710A1 (en) * 2017-05-22 2018-11-29 The Regents Of The University Of California Micro/nanobubble solutions for tissue preservation and generation thereof
TWI635469B (zh) * 2017-08-29 2018-09-11 國立臺北商業大學 用於反應力訓練的電腦程式產品
TWI634528B (zh) * 2017-08-29 2018-09-01 國立臺北商業大學 用於評估認知能力的電腦程式產品
KR102121417B1 (ko) * 2018-10-08 2020-06-10 가천대학교 산학협력단 Stat3 활성화제를 이용한 골격근세포 분화 유도용 조성물 및 이를 이용한 골격근세포 분화 유도 방법
CN109513037B (zh) * 2018-11-14 2021-09-17 华中科技大学同济医学院附属协和医院 一种负载介孔生物玻璃的小肠粘膜下层创面敷料
EP3927383A4 (en) * 2019-02-18 2022-11-09 Lankenau Institute for Medical Research SCAR REDUCING WOUND CLOSURE MATERIALS
CN110288581B (zh) * 2019-06-26 2022-11-04 电子科技大学 一种基于保持形状凸性水平集模型的分割方法
JP2024509661A (ja) * 2020-12-22 2024-03-05 フルイデックス メディカル テクノロジー，インコーポレイテッド 一過性造影剤入りの、その場で固化する注入可能な組成物、並びにそれらの製造及び使用方法
WO2023039353A2 (en) * 2021-09-08 2023-03-16 The Board Of Trustees Of The University Of Illinois Real-time super-resolution ultrasound microvessel imaging and velocimetry
CN114010163B (zh) * 2021-12-02 2023-12-19 中国中医科学院医学实验中心 基于光学成像的表皮细胞迁移定位系统及方法
CN114469897B (zh) * 2022-01-12 2023-02-28 上海市胸科医院 靶向治疗心肌梗死的锂皂石复合递送材料及其制备与应用
CN115177786A (zh) * 2022-07-14 2022-10-14 山东大学 一种原位负载蒙脱土/纳米羟基磷灰石的壳聚糖复合支架材料及其制备方法
CN117547554B (zh) * 2024-01-12 2024-05-14 山东康根源生物集团有限公司 一种间充质干细胞修复制剂及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
JPH03297475A (ja) * 1990-04-16 1991-12-27 Ken Ishihara 共振音波により薬物の放出を制御する方法
US5558082A (en) 1995-01-09 1996-09-24 Spencer; Robert F. Method of intubating a patient and introducer for use with such method
DE69724599T2 (de) 1996-03-12 2004-08-05 The Board Of Regents Of The University Of Nebraska, Lincoln Zusammensetzung zur zielortspezifischen verabreichung eines medikamentes und verfahren zur anwendung
US6896659B2 (en) 1998-02-06 2005-05-24 Point Biomedical Corporation Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
GB9826658D0 (en) 1998-12-03 1999-01-27 Univ London Tissue repair
DE60205906T2 (de) 2001-06-12 2006-06-08 Vivoxid Oy Poröses schwammartiges Cellulosematerial zur Behandlung von Verletzungen
CN1688301A (zh) 2002-08-20 2005-10-26 普罗特米克斯公司 药物剂型及相关的治疗用途
WO2004017956A1 (en) 2002-08-20 2004-03-04 Protemix Corporation Limited Dosage forms and related therapies
KR20140013078A (ko) 2004-11-07 2014-02-04 쿠프론 인코포레이티드 상처, 화상 및 다른 피부 질환을 치료하기 위한 구리 함유 물질
US20070048387A1 (en) * 2005-09-01 2007-03-01 Edwards Jeffrey D Tissue disruption treatment and composition for use thereof
WO2008057443A2 (en) 2006-11-03 2008-05-15 Multiple Sclerosis Research Center Of New York Bone marrow-derived mesenchymal stem cells as a source of neural progenitors
US8287896B2 (en) 2010-01-06 2012-10-16 The Curators Of The University Of Missouri Scaffolds with trace element for tissue regeneration in mammals
US8481066B2 (en) 2009-07-16 2013-07-09 The Curators Of The University Of Missouri Scaffold for tissue regeneration in mammals
EP2453844B1 (en) * 2009-07-16 2020-09-02 The Curators Of The University Of Missouri Scaffolds with trace element for tissue regeneration in mammals
CN102302507B (zh) * 2010-07-12 2014-02-05 四川大学华西医院 定向控释微量元素的药物组合物及制备方法和应用
CN101926821B (zh) 2010-07-12 2012-01-25 四川大学华西医院 一种靶向释放微量元素的药物组合物及制备方法和应用
CN103502218B (zh) 2011-03-04 2016-08-17 生命科技公司 用于缀合生物分子的化合物和方法
JP5598864B2 (ja) * 2011-12-05 2014-10-01 北海道公立大学法人 札幌医科大学 細胞増殖方法ならびに組織の修復および再生のための医薬
CN103467578B (zh) * 2012-06-08 2015-07-08 四川大学华西医院 一种短肽、载铜纳米生物材料及在制备治疗脑梗死的药物中的应用
WO2014027474A1 (ja) * 2012-08-17 2014-02-20 株式会社Ｃｌｉｏ 心筋梗塞の修復再生を誘導する多能性幹細胞
IN2014MN00938A (es) 2012-08-28 2015-04-24 Original Biomedicals Co Ltd
WO2014132262A1 (en) 2013-02-28 2014-09-04 Ramot At Tel-Aviv University Ltd. Peptide-based hydrogel particles and uses thereof
CN106278907B (zh) 2014-12-17 2019-06-21 四川科瑞德凯华制药有限公司 一种盐酸曲恩汀化合物
WO2016168993A1 (en) 2015-04-22 2016-10-27 Innolife Co., Ltd. Methods of tissue repair and regeneration
WO2017049529A1 (en) 2015-09-24 2017-03-30 Innolife Co., Ltd. A pharmaceutical composition comprising a copper chelating tetramine and the use thereof

Also Published As

Publication number Publication date
IL255116B (en) 2020-10-29
HK1247825A1 (zh) 2018-10-05
CO2017010382A2 (es) 2018-01-05
AU2016250971A1 (en) 2017-11-02
HUE056650T2 (hu) 2022-02-28
ECSP17068922A (es) 2018-02-28
CA2982840A1 (en) 2016-10-27
DK3285782T3 (da) 2021-12-06
KR20170137919A (ko) 2017-12-13
WO2016169416A1 (en) 2016-10-27
JP2020143158A (ja) 2020-09-10
CN107921062A (zh) 2018-04-17
UA124332C2 (uk) 2021-09-01
EA201792307A1 (ru) 2018-06-29
EP3285782A1 (en) 2018-02-28
US11077138B2 (en) 2021-08-03
KR20200000458A (ko) 2020-01-02
ES2898655T3 (es) 2022-03-08
EA038598B1 (ru) 2021-09-21
EP3285782B1 (en) 2021-09-08
WO2016168993A1 (en) 2016-10-27
SG11201708431QA (en) 2017-11-29
TW201642876A (zh) 2016-12-16
MY189322A (en) 2022-02-04
IL255116A0 (en) 2017-12-31
HK1251181A1 (zh) 2019-01-25
TWI702956B (zh) 2020-09-01
KR102347010B1 (ko) 2022-01-04
BR112017022355A2 (pt) 2018-07-10
JP6895388B2 (ja) 2021-06-30
US20180099008A1 (en) 2018-04-12
CN107921062B (zh) 2021-03-02
AU2016250971B2 (en) 2021-04-29
JP2018520090A (ja) 2018-07-26
NZ736516A (en) 2019-04-26
CL2017002600A1 (es) 2018-03-23
EP3285782A4 (en) 2018-12-12
PE20180240A1 (es) 2018-01-31
CA2982840C (en) 2022-10-25

Similar Documents

Publication Publication Date Title
MX2017013122A (es) Metodos de reparacion y regeneracion tisular.
AU2018236742B2 (en) Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same
CY1120729T1 (el) Πεπτιδια και συνθεσεις για τη θεραπεια τραυματισμου των αρθρωσεων
PH12016501411A1 (en) Bifunctional cytotoxic agents
MX2019007276A (es) Composiciones y métodos para mejora o aumento de la producción de ifn tipo i.
BR112017000301A2 (pt) tratamento de leucemia com inibidores de histona desacetilase
CL2017002719A1 (es) Imidazopirazinonas como inhibidores de pde1
WO2015171558A3 (en) BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
MX2022002056A (es) Compuestos para el tratamiento de enfermedad respiratoria bovina o porcina.
BR112017014361A2 (pt) métodos para aperfeiçoamento de terapia celular
CO2019003865A2 (es) Proteína terapéutica
MY185691A (en) An asseointegrable device
CL2019000032A1 (es) Uso de oxido de aleno sintasa para la preservación de semen y la reproducción asistida (divisional solicitud 201603067)
UA117933C2 (uk) Поліпептид, здатний зв'язувати с5-компонент комплементу людини
MX2018004041A (es) Tratamiento de trastornos de acidos biliares.
MX2020000636A (es) Proteinas sinteticas y usos terapeuticos de las mismas.
MY176976A (en) Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions
BR112015024877A2 (pt) vacinas que compreendem polipeptídeos de leishmania para o tratamento e diagnóstico de leishmaniose
BR112017025447A2 (pt) angiogêse utilizando células-tronco da placenta estimuladas
PH12015502037A1 (en) Activating adiponectin by casein hydrolysate
WO2015100423A3 (en) Methods for treating cancer with ghrh agonists
WO2015008152A3 (en) Methods and compositions for blood vessel tissue repair and engineering
TH180250A (th) อุปกรณ์สำหรับการนำส่งสิ่งปลูกฝังเทียมและวิธีการใช้พวกมัน
UA118032U (uk) Фармацевтична композиція